Contact this trialFirst, we need to learn more about you.
Small Molecule
Enpatoran for Lupus
Recruiting0 awardsPhase 2
South Jordan, Utah
This trial is testing M5049 to see if it is an effective and safe treatment for lupus over 24 weeks. It is a randomized, double-blind, placebo-controlled, adaptive and dose-ranging study, which means that participants are randomly assigned to either receive the drug or a placebo, and neither they nor the researchers know who is receiving which. The study will last 33 weeks and participants will visit the clinic every 2 or 4 weeks.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.